Ghiselli G, Krishnan S, Beigel Y, Gotto A M
J Lipid Res. 1986 Aug;27(8):813-27.
As assessed by molecular sieve chromatography and quantitation by a specific radioimmunoassay, apoA-IV is associated in plasma with the triglyceride-rich lipoproteins, to a high density lipoprotein (HDL) subfraction of smaller size than HDL3, and to the plasma lipoprotein-free fraction (LFF). In this study, the turnover of apoA-IV associated to the triglyceride-rich lipoproteins, HDL and LFF was investigated in vivo in normal volunteers. Human apoA-IV isolated from the thoracic duct lymph chylomicrons was radioiodinated and incubated with plasma withdrawn from normal volunteers after a fatty meal. Radioiodinated apoA-IV-labeled triglyceride-rich lipoproteins, HDL, and LFF were then isolated by chromatography on an AcA 34 column. Shortly after the injection of the radioiodinated apoA-IV-labeled triglyceride-rich lipoproteins, most of the radioactivity could be recovered in the HDL and LFF column fractions. On the other hand, when radioiodinated apoA-IV-labeled HDL or LFF were injected, the radioactivity remained with the originally injected fractions at all times. The residence time in plasma of 125I-labeled apoA-IV, when injected in association with HDL or LFF, was 1.61 and 0.55 days, respectively. When 125I-labeled apoA-IV was injected as a free protein, the radioactivity distributed rapidly among the three plasma pools in proportion to their mass. The overall fractional catabolic rate of apoA-IV in plasma was measured in the three normal subjects and averaged 1.56 pools per day. The mean degradation rate of apoA-IV was 8.69 mg/kg X day. The results are consistent with the conclusions that: apoA-IV is present in human plasma in three distinct metabolic pools; apoA-IV associated with the triglyceride-rich lipoproteins is a precursor to the apoA-IV HDL and LFF pools; apoA-IV in LFF is not a free protein and its turnover rate is faster than that of apoA-IV in HDL; since no transfer of apoA-IV from the HDL or the LFF occurs, these pools may represent a terminal pathway for the catabolism of apoA-IV; and the catabolism of apoA-IV in HDL is dissociated from that of apoA-I although both apoproteins may reside on the same lipoprotein particles.
通过分子筛色谱法评估并用特异性放射免疫测定法定量,载脂蛋白A-IV在血浆中与富含甘油三酯的脂蛋白、比HDL3尺寸更小的高密度脂蛋白(HDL)亚组分以及血浆无脂蛋白组分(LFF)相关联。在本研究中,在正常志愿者体内研究了与富含甘油三酯的脂蛋白、HDL和LFF相关的载脂蛋白A-IV的周转率。从胸导管淋巴乳糜微粒中分离出的人载脂蛋白A-IV经放射性碘化,并与高脂餐后从正常志愿者抽取的血浆一起孵育。然后通过在AcA 34柱上进行色谱分离,分离出放射性碘化的载脂蛋白A-IV标记的富含甘油三酯的脂蛋白、HDL和LFF。在注射放射性碘化的载脂蛋白A-IV标记的富含甘油三酯的脂蛋白后不久,大部分放射性可在HDL和LFF柱级分中回收。另一方面,当注射放射性碘化的载脂蛋白A-IV标记的HDL或LFF时,放射性始终保留在最初注射的级分中。当与HDL或LFF一起注射时,125I标记的载脂蛋白A-IV在血浆中的停留时间分别为1.61天和0.55天。当125I标记的载脂蛋白A-IV作为游离蛋白注射时,放射性根据三个血浆池的质量比例迅速分布在其中。在三名正常受试者中测量了血浆中载脂蛋白A-IV的总体分解代谢率,平均为每天1.56个池。载脂蛋白A-IV的平均降解率为8.69mg/kg×天。结果与以下结论一致:载脂蛋白A-IV以三种不同的代谢池形式存在于人体血浆中;与富含甘油三酯的脂蛋白相关的载脂蛋白A-IV是载脂蛋白A-IV HDL和LFF池的前体;LFF中的载脂蛋白A-IV不是游离蛋白,其周转率比HDL中的载脂蛋白A-IV快;由于载脂蛋白A-IV不会从HDL或LFF转移,这些池可能代表载脂蛋白A-IV分解代谢的终末途径;并且HDL中载脂蛋白A-IV的分解代谢与载脂蛋白A-I的分解代谢无关,尽管这两种载脂蛋白可能存在于相同的脂蛋白颗粒上。